Aimei Health Technology (AFJK) Return on Equity (2024 - 2025)

Aimei Health Technology (AFJK) reported Return on Equity of 0.0% for Q3 2025, up 3.0% year-over-year from 0.0% in Q3 2024, and up 35.09% quarter-over-quarter from 0.01% in Q2 2025.

Aimei Health Technology (AFJK) Return on Equity (2024 - 2025) Analysis & Trends

Aimei Health Technology (AFJK) has 2 years of Return on Equity data on file, last reported at 0.0% in Q3 2025.

  • Return on Equity for Q3 2025 came in at 0.0%, up 3.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.0% (up 3.0% YoY), and the FY2024 annual result was 0.03%, changed N/A from the prior year.
  • Return on Equity grew to 0.0% in Q3 2025 per AFJK's latest filing, from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q3 2025 and troughed at 0.03% in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -0.01%
2 Berto Acquisition 312.46 Mn 312.46 Mn - -0.01%
3 Centurion Acquisition 311.65 Mn 311.65 Mn - -0.01%
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - -0.01%
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -0.01%
6 WEN Acquisition 309.15 Mn 309.15 Mn - -0.01%
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - -0.01%
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - 0.00%
9 BTC Development 262.16 Mn 262.16 Mn - 0.00%
10 Aimei Health Technology 176.90 Mn 176.90 Mn - 0.00%

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00%
Jun 30, 2025 -0.01%
Mar 31, 2025 -0.01%
Dec 31, 2024 -0.02%
Sep 30, 2024 -0.03%